Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Industry

Why We Wrote the Living Proof Standard for Data Stories

Sreepriya Prasannan
Sreepriya Prasannan

NewsWritten by our team from the primary sources linked below. Reviewed, verified and approved by a human editor. How we check

Speed:
Why We Wrote the Living Proof Standard for Data Stories

Living Proof is the standard Priya Life Science now uses for its data stories. Every claim says what it stands on, every number can be recalculated on the reader's own device, the conclusion is tested in public, and the story keeps reporting after publication. The full rules are published as the Living Proof Standard.

It adds to the usual rules of journalism. It does not replace them. The first story written to it, Living Proof No. 1 on Ireland's clinical trials, went live on 15 November 2026.

Why we wrote a standard

Most data journalism asks readers to trust three things at once: that the numbers were calculated correctly, that the documents say what the reporter says they say, and that the finding would survive a different way of counting. The usual answer is a methods note at the end of the story. A reader can read it, but cannot test it.

We report on medicines, clinical trials and health spending in Ireland. These are subjects where a wrong number can mislead patients, clinicians and policymakers. So we decided that our data stories should hand over the working, not just describe it.

The five promises

The five promises are the summary. A story may carry the Living Proof name only if it meets every requirement in the standard, which has the full rules and a checklist, or says in its edition record which one it does not yet meet and why.

  1. Every claim says what it stands on. Each claim is marked as one of four kinds: Computed (our code calculated it from public data), Sourced (it comes from a document we read, linked and dated), Said (a named person said it on the record) or Our reading (our analysis, always labelled as such).
  2. Every number can be re-run by the reader. The data file is fingerprinted and archived with a DOI. The code is public. A button in the story downloads the same records and recalculates every published number in the reader's browser.
  3. The conclusion is attacked in public. We publish the other ways we tried to count, including any where the finding does not hold. We also state what evidence would change our mind.
  4. The story stays alive. A live layer, fed by our open data engine Airmid Éireann, reports what has changed since publication. The story shows its own age.
  5. Every change is visible. Corrections show the old value, the new value, the date and the reason, and are logged on our corrections page.

A story that breaks a requirement without saying so loses the Living Proof name until it is fixed.

What it looks like in the first story

Living Proof No. 1 asks whether Ireland is getting its share of clinical trials. It rests on 39 computed numbers, 11 sourced facts, one quotation and seven labelled readings. Its "Run the check" button downloads the 47,265 trial records behind the story, confirms the file has the same fingerprint as the archived copy, and recalculates every published number. The story tests its finding 18 other ways and shows the one comparison where it does not hold. Before publication we asked the Department of Health, the Health Research Board and the National Clinical Trials Office for a reply; the story says that none replied by the deadline and that any reply will be added with its date.

The story also admits where it falls short of its own standard. It was built before the standard was written, so there was no analysis plan dated before the numbers were run. Its edition record says so.

How it compares with existing codes

Living Proof sits on top of the codes journalists already follow, and we apply their principles of accuracy, fairness and the separation of fact and comment. Mentioning these codes does not mean Priya Life Science is a member or signatory of either body.

QuestionThe usual standardWhat Living Proof adds
Is it accurate?The Press Council of Ireland Code, Principle 1: publications "shall strive at all times for truth and accuracy".The reader can check the numbers themselves, on their own device, against an archived file.
Can I tell fact from comment?Press Council Code, Principle 2, Distinguishing Fact and Comment.Every sentence of analysis is labelled "Our reading" where it appears, not only in a separate opinion section.
Where does it come from?The IFCN Code of Principles asks for sources "in enough detail that readers can replicate their work".Each claim opens to its source, date and caveat, and the computed claims open to their formula and inputs.
How was it done?The IFCN Code asks signatories to explain their methodology.The method is the code itself, run on the page, with a stress test and a stated "what would change our mind".
What if it is wrong?Press Council Code 1.2: significant errors "shall be corrected promptly and with due prominence". The IFCN asks for an open corrections policy.Every correction shows the old and new value inside the story's edition record, as well as on the corrections page.
Is it still true?Most stories are fixed on the day they are published.A live layer reports new data after publication, labelled provisional until the next checked edition.

How we use AI

We use AI tools, and we say exactly where. They help us find documents, write and test code, draft text that an editor then rewrites, and act as one extra reviewer. No number in a Living Proof story is produced by an AI model: every number is calculated by code from public files, and the reader's check is plain code that gives the same answer every time. No quotation is generated. A human editor reviews, verifies and approves every edition before it is published, and each story's edition record states how AI was used for that story.

What we build on

Others have pushed data journalism towards openness, and we credit them. Proof News puts an "ingredients label" on its stories. Newsrooms have long published their code and data, and Tomas Petricek's The Gamma project let readers see and change the code behind a chart. In May 2026 the data journalist S Anand proposed a "Verify" button for news stories, and in June 2026 researchers described Data2Story, in which AI agents link claims to data and re-run them. Living Proof combines four things we have not seen together in one published story: recalculation on the reader's device, typed evidence for every claim, a public stress test, and a live layer after publication.

Use it yourself

The standard, the engine and the data are open. The code is on GitHub under the EUPL-1.2 licence, and the data behind No. 1 is archived on Zenodo under CC BY 4.0. Newsrooms, researchers and students may reuse the format; please credit "Living Proof Standard, Priya Life Science" and link to the standard. Tell us about errors at info@priyalifescience.com.

Frequently asked questions

What does "re-runnable journalism" mean?

It means a reader can repeat the calculation behind each number in a story and get the same answer. In a Living Proof story this happens in the reader's own browser, from the same archived data file we used.

Does the check prove the story is true?

No. It proves that the published numbers follow from the published data and code. Whether the data measures the right thing is a separate question, which the stress test and the "what this cannot tell you" section address.

Is an AI model checking the numbers?

No. The check is ordinary code that gives the same result every time it runs. AI tools help us with research and drafting, and a human editor approves every story.

Can other newsrooms use the format?

Yes. The standard is published under CC BY 4.0 and the code under the EUPL-1.2. We ask for credit and a link to the standard.

Outlook

The next Living Proof story looks at Irish hospital waiting lists, followed by stories on Irish pharma exports and on how long new medicines take to reach Irish patients. Each will be listed on the Living Proof page with its own archived data file. Living Proof No. 1 will be re-run with a new edition in January 2027.

Sources

Cover image: AI-generated illustration.

Reviewed for editorial accuracy by Sreepriya Prasannan, Founder & Editor MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany
Our standards
Most-trialled drugs in our registers
Browse all trial registers →

Get the Friday brief

One email every Friday: a 60-second summary, then only the topics you choose: industry news, approvals and market access, shortages, Irish trials, careers or data, all built from public registers.

Free. Unsubscribe from any email with one click. See our privacy policy.

About the Author
Sreepriya Prasannan

Sreepriya Prasannan

Writer at Priya Life Science · Industry

Sreepriya Prasannan is the Founder and Editor of Priya Life Science, Ireland's independent pharma, biotech and MedTech platform. She holds an MSc in Digital Transformation (Life Science) from Griffith College Dublin, with a background in QA, GMP and production operations. Shortlisted for STEM Graduate of the Year at the Business Post Women in STEM Awards 2026 and a Top 14 finalist in the HSE Spark Ignite 2026 innovation programme, she writes on regulatory trends, GMP compliance and careers across the Irish and European life sciences.

Discussion
No comments yet. Be the first to share your thoughts!
Leave a Comment